Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Suraksha Diagnostic IPO is 39. Their analysis recommends Do Not Subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 39 | Do Not Subscribe |
[Dilip Davda] The company is a one-stop pathology and radiology testing, and medical consultation services solution provider having East region centric play. It enjoys market share of around 1.26% in the area of its operation and that is scaling up with its new centre opening, which adds to its top line and over the period start contributing to its bottom line. It suffered a minor setback for FY23 due to non-contribution of such centres opened in FY22 and their related expenses. However, the company is back on track as indicated by FY24 performance and is poised for bright prospects with its expansion plans afoot. Based on FY25 annualized earnings, the issue appears fully priced discounting all near term positives. However, well-informed investors may park funds for long term. Read detail review...
Suraksha Diagnostic Limited peer comparison with similar listed entities. (As on March 28, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Suraksha Diagnostic Limited | 4.43 | 4.43 | 33.66 | 14.09 | Consolidated | ||
| Dr Lalchandani Labs Ltd | 43.05 | 42.98 | 221.47 | 77.08 | 20.35 | 0.07 | |
| Metropolis Healthcare Ltd | 24.95 | 24.87 | 213.98 | 89.61 | 12.26 | 8.05 | |
| Thyrocare Technologies Ltd | 13.42 | 13.40 | 99.48 | 65.52 | 13.34 | 5.93 | |
| Vijaya Diagnostic Centre Limited | 11.62 | 11.59 | 64.21 | 86.40 | 19.77 | 9.91 |
Notes:
Suraksha Diagnostic IPO Reviews, analysis and views by popular members. Read Suraksha Diagnostic Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP